1.
Mato AR, Tang B, Azmi S, Yang K, Zhang X, Stern JC, Hedrick E, Huang J, Sharman JP. A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib. haematol [Internet]. 2022Apr.21 [cited 2022Nov.28];107(11):2630-4. Available from: https://haematologica.org/article/view/haematol.2021.280376